Research, space, energy and the science behind the tech.
Great British Energy is opening the first slice of a £1 billion community energy pot, though most of the headline figures are targets rather than guarantees.
A British High Commission press release trumpets eight Indian award-winners, but the fine print shows this is recognition, not funding - yet.
The money is real and the wood really is decaying – but this is a rescue excavation, not a discovery announcement, and nobody yet knows what it will find.
A new government strategy talks up satellite defences and better phone signal on trains, but most of the money is a spending plan through to 2030, not kit that exists yet.
The MoD says Royal Marines and RAF personnel just proved NATO can fight in the High North - but strip out the press-release language and it's a routine, if chilly, training exercise.
Downing Street says manslaughter and historic grooming cases are now excluded from sentencing changes, but there's no bill, no numbers and no date attached to the announcement.
A new opt-in service will text or email you when air quality turns bad in your area, though nothing changes unless you sign up yourself.
A fresh diplomatic appointment has landed on GOV.UK - here's what's actually confirmed, and why it's mostly irrelevant to your day-to-day tech life.
A ministerial trip to Cambodia is really a diplomatic photo-op - but the demining operation behind it is a genuine, measurable piece of humanitarian engineering worth separating from the rhetoric.
A joint statement condemns new construction tenders in the West Bank's E1 zone and warns businesses of 'legal and reputational consequences' - but there's no sanction, ban or enforcement mechanism attached.
A £442 million package and a promise sound big, but the smallprint shows a familiar gap between ambition and delivery.
A new analysis of the SELECT trial reports a lower predicted dementia risk on semaglutide. But it measured a blood-protein signature, not actual dementia, and the drug's dedicated Alzheimer's trials found no clinical benefit last November.
AMIE reads visual and audio cues and guides a virtual physical examination. Clinicians rated it well, against simulated patients, in a research setting Google says is not ready for real use.
